Shortages and price variability of essential cytotoxic medicines for treating children with cancers

INTRODUCTION: Low-income and middle-income countries (LMICs) face the largest burden of mortality from childhood cancers with limited access to curative therapies. Few comparative analyses across all income groups and world regions have examined the availability and acquisition costs of essential medicines for treating cancers in children. METHODS: A cross-sectional survey involved countries in five income groups-low-income (LIC), …